Select a community
All Communities
Home > Community Treatment Reports > Amphetamine-Dextroamphetamine Treatment Report
What is Amphetamine-Dextroamphetamine?

The combination of dextroamphetamine and amphetamine is in a class of medications called central nervous system stimulants. It is used as part of a treatment program for attention deficit hyperactivity disorder (ADHD). Also used to treat narcolepsy, a sleep disorder causing sudden sleep attacks.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken
# of patients Efficacy
Major
Moderate
Slight
None
Can’t tell
# of patients evaluated by
Fatigue 168 46
Problems concentrating 90 39
Other 64 20
Attention Deficit Hyperactivty Disorder ADD/ADHD 56 28
Treat my mood condition(s) 40 11
ADHD-Combined Type 32 12

See all 495 patients currently taking Amphetamine-Dextroamphetamine

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
9 5%
Moderate
45 26%
Mild
62 35%
None
60 34%

Most commonly reported side effects

Insomnia
33 31%
Weight loss
28 26%
dry mouth
28 26%
Anxiety
22 20%
Restlessness
19 18%
Always feel urgent need to be doing something productive
17 16%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Amphetamine-Dextroamphetamine. See all 38 dosages

  10 mg as needed 10mg as needed 15mg as needed 20mg as needed 30mg as needed 3 20mg as needed 3 5mg as needed 3 mg as needed 4 30mg as needed 50mg as needed 5mg as needed 7.5mg as needed as needed daily mg as needed 10 mg 1.5 mg daily 5 mg daily 7.5 mg daily 10 mg daily 15 mg daily 20 mg daily 22.5 mg daily 25 mg daily 30 mg daily 40 mg daily 45 mg daily 50 mg daily 55 mg daily 60 mg daily 75 mg daily 80 mg daily 90 mg daily 100 mg daily 105 mg daily 120 mg daily 600 mg daily 1200 mg daily
  3 Number of Patients: 3 6 Number of Patients: 6 1 Number of Patients: 1 5 Number of Patients: 5 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 6 Number of Patients: 6 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 21 Number of Patients: 21 2 Number of Patients: 2 64 Number of Patients: 64 17 Number of Patients: 17 120 Number of Patients: 120 1 Number of Patients: 1 16 Number of Patients: 16 84 Number of Patients: 84 71 Number of Patients: 71 2 Number of Patients: 2 6 Number of Patients: 6 1 Number of Patients: 1 62 Number of Patients: 62 1 Number of Patients: 1 7 Number of Patients: 7 5 Number of Patients: 5 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Amphetamine-Dextroamphetamine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
26 31% Side effects too severe: 31%
Other
25 30% Other: 30%
Doctor's advice
21 25% Doctor's advice: 25%
Did not seem to work
20 24% Did not seem to work: 24%
Expense
8 10% Expense: 10%
Personal research
4 5% Personal research: 5%
Not indicated
3 4% Not indicated: 4%
Course of treatment ended
2 2% Course of treatment ended: 2%
Change in health plan coverage
1 1% Change in health plan coverage: 1%

See all 79 patients who’ve stopped taking Amphetamine-Dextroamphetamine

Currently Taking Amphetamine-Dextroamphetamine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Amphetamine-Dextroamphetamine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
111 63%
Usually
50 28%
Sometimes
14 8%
Never
1 1%

Burden

Difficulty being on treatment

Very
6 3%
Somewhat
15 9%
A little
35 20%
Not at all
120 68%

Cost

Paid out of pocket

$200+
1 1%
$100-199
7 4%
$50-99
13 7%
$25-49
26 15%
< $25
85 48%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 18, 2010.